PMID- 28267559 OWN - NLM STAT- MEDLINE DCOM- 20170328 LR - 20170328 IS - 1879-3169 (Electronic) IS - 0378-4274 (Linking) VI - 271 DP - 2017 Apr 5 TI - Site-specific neural hyperactivity via the activation of MAPK and PKA/CREB pathways triggers neuronal degeneration in methylmercury-intoxicated mice. PG - 66-73 LID - S0378-4274(17)30094-2 [pii] LID - 10.1016/j.toxlet.2017.03.001 [doi] AB - Methylmercury (MeHg) induces site-specific neurotoxicity in the adult brain. In this study, we investigated the site-specific expression of the signaling cascade related to neural activity in a mouse model of MeHg intoxication showing neurodegeneration only in the deep layer of the cerebral cortex, especially layer IV. We performed time course studies of c-fos and brain-derived neurotrophic factor (BDNF) expression levels which are proper markers of neural activity. We showed that upregulation of both markers preceded the neuronal degeneration in the cerebral cortex. Immunohistochemical analysis revealed the site-specific upregulation of c-fos in the deep layer of the cerebral cortex. Western blot analysis showed that c-fos and BDNF expression was associated with CREB phosphorylation, which was triggered by the activation of the p44/42 MAPK, p38 MAPK and PKA pathways. However, we did not detect any changes in the expression levels of c-fos and BDNF proteins and no signs of neuronal degeneration in the hippocampus and cerebellum, despite the fact that we could detect accumulation of MeHg in these two brain regions. These results suggested an intriguing possibility that MeHg-induced neuronal degeneration was caused by site-specific neural hyperactivity triggered by the activation of MAPK and PKA/CREB pathways followed by c-fos and BDNF upregulation. CI - Copyright (c) 2017 Elsevier B.V. All rights reserved. FAU - Fujimura, Masatake AU - Fujimura M AD - Department of Basic Medical Sciences, National Institute for Minamata Disease, 4058-18 Hama, Minamata, Kumamoto 867-0008, Japan. Electronic address: fujimura@nimd.go.jp. FAU - Usuki, Fusako AU - Usuki F AD - Department of Clinical Medicine, National Institute for Minamata Disease, Kumamoto, Japan. LA - eng PT - Journal Article DEP - 20170304 PL - Netherlands TA - Toxicol Lett JT - Toxicology letters JID - 7709027 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Creb1 protein, mouse) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Methylmercury Compounds) RN - 0 (Proto-Oncogene Proteins c-fos) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Blotting, Western MH - Brain-Derived Neurotrophic Factor/metabolism MH - Cerebral Cortex/*drug effects/enzymology/pathology/physiopathology MH - Cyclic AMP Response Element-Binding Protein/*metabolism MH - Cyclic AMP-Dependent Protein Kinases/*metabolism MH - Disease Models, Animal MH - Enzyme Activation MH - Immunohistochemistry MH - Male MH - Mercury Poisoning, Nervous System/enzymology/pathology/physiopathology/*prevention & control MH - *Methylmercury Compounds MH - Mice, Inbred ICR MH - Mitogen-Activated Protein Kinases/*metabolism MH - *Nerve Degeneration MH - Neurons/*drug effects/enzymology/pathology MH - Phosphorylation MH - Proto-Oncogene Proteins c-fos/metabolism MH - Signal Transduction MH - Time Factors MH - Up-Regulation OTO - NOTNLM OT - C-fos OT - Deep layer of cerebral cortex OT - MAPK and PKA/CREB pathways OT - Methylmercury OT - Neural activity OT - Site-specific neurotoxicity EDAT- 2017/03/08 06:00 MHDA- 2017/03/30 06:00 CRDT- 2017/03/08 06:00 PHST- 2016/11/05 00:00 [received] PHST- 2017/01/17 00:00 [revised] PHST- 2017/03/02 00:00 [accepted] PHST- 2017/03/08 06:00 [pubmed] PHST- 2017/03/30 06:00 [medline] PHST- 2017/03/08 06:00 [entrez] AID - S0378-4274(17)30094-2 [pii] AID - 10.1016/j.toxlet.2017.03.001 [doi] PST - ppublish SO - Toxicol Lett. 2017 Apr 5;271:66-73. doi: 10.1016/j.toxlet.2017.03.001. Epub 2017 Mar 4.